文献速递新生儿儿童感染儿童消化与营养

母亲新冠检测阳性与极早产儿NICU结局

Maternal Coronavirus Disease 2019 Test Positivity and Neonatal Intensive Care Unit Outcomes for Infants Born Extremely Preterm.
PubMed 文献 · J Pediatr · 2025-09-26

该前瞻性研究纳入2020年3月至2023年4月16个NICHD新生儿研究网络中心的4548例极早产儿(出生体重401-1000 g和/或胎龄<29周),其母亲在孕期接受SARS-CoV-2检测。7%(297/4072)的母亲检测阳性,检测婴儿中1%(2/181)在<72小时龄阳性;母亲阳性与坏死性小肠结肠炎(NEC)风险升高相关,与其他结局及死亡无关。

要点

  • 极早产儿中SARS-CoV-2垂直传播不常见,<72小时龄检测阳性为1%(2/181)。
  • 母亲孕期SARS-CoV-2阳性与NEC风险升高相关(14% vs 11%;校正RR 1.40,95%CI 1.03-1.89;P=.03)。
  • 多数结局如支气管肺发育不良和早产儿视网膜病变在阳性与阴性母亲婴儿间无差异。

核心结论

  • 在胎龄<29周的极早产儿中,SARS-CoV-2垂直传播不常见;母亲SARS-CoV-2阳性与NEC相关,但与其他婴儿结局或死亡无关。

研究设计与样本

  • 前瞻性研究,2020年3月1日至2023年4月30日在16个Eunice Kennedy Shriver NICHD新生儿研究网络中心开展。
  • 纳入出生体重401-1000 g和/或胎龄<29周、母亲孕期接受SARS-CoV-2检测的院内出生婴儿。
  • 研究期间共4548例极早产儿出生于4072例孕期接受SARS-CoV-2检测的母亲。

主要发现

  • 7%(297/4072)的母亲SARS-CoV-2检测阳性;检测婴儿中1%(2/181)在<72小时龄阳性。
  • 多数结局(如支气管肺发育不良和早产儿视网膜病变)在检测阳性与阴性母亲所生婴儿间无差异。
  • 阳性母亲婴儿NEC诊断率高于阴性母亲婴儿(14% vs 11%;P=.03)。
  • 校正分析中,阳性母亲婴儿更易发生NEC(RR 1.40;95%CI 1.03-1.89;P=.03)或死亡(12小时龄内)或NEC复合结局(RR 1.33;95%CI 1.09-1.62;P<.01)。
  • 12小时龄内死亡(RR 1.22,95%CI 0.92-1.62;P=.16)或出院前死亡(RR 0.83,95%CI 0.55-1.26;P=.38)与母亲阳性无显著关联。

关键数值与推荐

  • 母亲SARS-CoV-2检测阳性率7%(297/4072)。
  • 婴儿<72小时龄SARS-CoV-2阳性率1%(2/181)。
  • NEC发生率:阳性母亲婴儿14% vs 阴性母亲婴儿11%(P=.03)。
  • 校正后NEC风险比RR 1.40(95%CI 1.03-1.89;P=.03)。
  • 校正后死亡(12小时龄内)或NEC复合结局RR 1.33(95%CI 1.09-1.62;P<.01)。

临床怎么用

  • 对极早产儿,母亲孕期SARS-CoV-2阳性不应作为垂直传播的高风险依据,<72小时龄检测阳性率低。
  • 母亲孕期SARS-CoV-2阳性的极早产儿需关注NEC风险,加强相关监测。
  • 母亲阳性与12小时龄内死亡、出院前死亡无显著关联,死亡风险咨询应结合其他因素。

局限性

  • 原文未报告局限性相关内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To describe the neonatal intensive care unit outcomes of infants born extremely preterm to mothers who test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy. STUDY DESIGN: Prospective study (March 1, 2020-April 30, 2023) at 16 Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network centers of inborn infants (birth weight 401-1000 g and/or gestational age <29 weeks) born to mothers tested for SARS-CoV-2 during pregnancy. Frequency of maternal SARS-CoV-2 detection, vertical transmission rate, and association of maternal SARS-CoV-2 positivity during pregnancy with infant outcomes were determined. RESULTS: During the 38-month study, 4548 extremely preterm infants were born to 4072 mothers tested for SARS-CoV-2 during pregnancy. Overall, 7% (297/4072) of mothers had a positive SARS-CoV-2 test; 1% (2/181) of tested infants were positive at age <72 hours. The majority of outcomes (eg, bronchopulmonary dysplasia and retinopathy of prematurity) did not differ between infants of test-positive vs test-negative mothers. Infants of test-positive mothers were more likely to be diagnosed with necrotizing enterocolitis (NEC) than those of test-negative mothers (14% vs 11%; P = .03). In adjusted analyses, infants born to test-positive mothers were more likely to develop NEC (risk ratio [RR] 1.40; 95% CI, 1.03-1.89; P = .03) or the combined outcome of death within 12 hours of age or NEC (RR 1.33; 95% CI, 1.09-1.62; P < .01) but not death within 12 hours of age (RR 1.22, 95% CI, 0.92-1.62; P = .16) or before discharge (RR 0.83, 95% CI, 0.55-1.26; P = .38). CONCLUSIONS: Among infants <29 weeks' gestation, vertical transmission of SARS-CoV-2 was infrequent. Maternal SARS-CoV-2 positivity was associated with NEC but not with other infant outcomes or mortality. TRIAL REGISTRATION: ClinicalTrials.gov ID. Generic Database: NCT00063063. https://clinicaltrials.gov/study/NCT00063063.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Messick EA, Saha S, Slaughter JL, et al. Maternal Coronavirus Disease 2019 Test Positivity and Neonatal Intensive Care Unit Outcomes for Infants Born Extremely Preterm. J Pediatr. 2025. PMID: 41016465. doi:10.1016/j.jpeds.2025.114840

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。